GSA CAPITAL PARTNERS LLP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$735
+81.5%
279,629
+143.8%
0.06%
+57.5%
Q2 2023$405
+31.1%
114,698
+57.2%
0.04%
+5.3%
Q4 2022$309
-99.9%
72,940
-48.0%
0.04%
-13.6%
Q3 2022$333,000
+69.9%
140,321
+104.1%
0.04%
+51.7%
Q2 2022$196,000
-51.0%
68,749
-50.5%
0.03%
-46.3%
Q1 2022$400,000
-33.7%
138,943
+61.5%
0.05%
-11.5%
Q3 2021$603,000
+340.1%
86,040
+478.0%
0.06%
+306.7%
Q2 2021$137,000
-81.3%
14,885
-82.2%
0.02%
-82.4%
Q4 2019$732,000
+177.3%
83,686
+241.6%
0.08%
+136.1%
Q3 2019$264,000
-30.2%
24,500
-17.6%
0.04%
-14.3%
Q2 2019$378,000
+51.2%
29,718
+361.8%
0.04%
+68.0%
Q1 2019$250,000
-93.8%
6,435
-81.4%
0.02%
-83.9%
Q2 2015$4,042,000
+54.0%
34,625
+211.5%
0.16%
+49.0%
Q1 2015$2,624,000
+202.0%
11,114
+142.0%
0.10%
+70.5%
Q4 2014$869,000
-55.0%
4,593
-43.3%
0.06%
-40.2%
Q3 2014$1,932,000
+18.2%
8,099
-48.4%
0.10%
-12.1%
Q1 2014$1,635,000
+165.0%
15,698
+36.5%
0.12%
+136.7%
Q3 2013$617,000
+61.5%
11,500
+33.7%
0.05%
+8.9%
Q2 2013$382,0008,6000.04%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders